Unlock instant, AI-driven research and patent intelligence for your innovation.

Genetically modified immune cell as well as preparation method and application thereof

A technology of immune cells and coding genes, which is applied in the field of cellular immunotherapy, can solve the problems of inability to add functional components and further enrich the functions of CAR-T or CAR-NK cells, and achieve high-efficiency transfection, enhanced clearance, and enriched functions Effect

Pending Publication Date: 2020-11-27
SHENZHEN IN VIVO BIOMEDICINE TECH LTD
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this technology can only target antigens recognizable by NKG2D, and cannot add more functional elements due to the limitation of viral vector load, and cannot further enrich the functions of CAR-T or CAR-NK cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Genetically modified immune cell as well as preparation method and application thereof
  • Genetically modified immune cell as well as preparation method and application thereof
  • Genetically modified immune cell as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Example 1 Design and Construction of CAR Molecular Carrier

[0067] In this example, the fragments with the complete DAP10 molecule and intracellular signal transduction domains of 4-1BB and CD3ζ were first synthesized, and connected to the pWPXLD-EGFP vector to construct the expression plasmid DAP10BB3 (abbreviated as DAP10), such as Figure 1A shown;

[0068] Subsequently, the scFv targeting GPC3 and Meothelin (including the IgG-CH3 region) were specifically amplified by PCR, and cloned into the above-mentioned expression plasmid DAP10, respectively, to obtain chimeric DAP10 cells targeting GPC3 (phosphatidylinositol protein 3). The CAR molecule antiGPC3-DAP10ec+tm+cd-BB3 (GPC3-DAP10 for short) of the outer and transmembrane region, 4-1BB and CD3ζ signal transduction domain, and the chimeric DAP10 targeting Mesothelin (mesothelin) extracellular and The CAR molecule antiMSLN-DAP10ec+tm+cd-BB3 (MSLN-DAP10 for short) of the transmembrane region, 4-1BB and CD3ζ signal tra...

Embodiment 2

[0069] Example 2 Overexpression of CAR virus packaging

[0070] Transform the constructed plasmid into Escherichia coli, select a single clone with the target plasmid for overnight culture, use a plasmid extraction kit to extract the plasmid, and carry out virus packaging;

[0071] Use 293T cells for virus packaging, transfect the helper plasmid and the expression plasmid with CAR molecules into 293T cells at the same time, harvest the first and second viruses after 48h and 72h respectively, filter and freeze at -80°C for T used for cell transduction.

Embodiment 3

[0072] Example 3 Construction of Genetically Modified T Cells Expressing CAR

[0073] First, mononuclear cells (PBMC) were isolated from adult peripheral blood, and the total T cells were sorted out using a T cell sorting kit. After being stimulated by CD3 and CD28 antibodies in vitro for 24 hours, the overexpressed CAR molecule prepared in Example 2 was added. 12 hours after transduction, the T cells were centrifuged to change the medium; three days after the transduction, the content of GFP-positive cells was measured by flow cytometry, and the ratio of CAR-T was evaluated; 2×10 cells were cultured per ml of medium. 6The density culture of 1 cell expands CAR-T cell, obtains DAP10-CAR-T (the amino acid sequence of DAP10-CAR is shown in SEQ ID NO:2), antiGPC3-DAP10-CAR-T (the amino acid sequence of antiGPC3-DAP10-CAR The sequence is shown in SEQ ID NO: 3), antiMSLN-DAP10-CAR-T (the amino acid sequence of antiMSLN-DAP10-CAR is shown in SEQ ID NO: 4) cells, and the cells were fr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a genetically modified immune cell as well as a preparation method and application thereof. The immune cell expresses a chimeric antigen receptor; the chimeric antigen receptorcomprises DAP10 and a signal transduction domain; the signal transduction domain is connected to a C end of the DAP10; the DAP10 is an extracellular domain, a transmembrane domain and an intracellulardomain of the chimeric antigen receptor; the chimeric antigen receptor further comprises an antigen binding domain; and the antigen binding domain is connected to an N end of the DAP10. The chimericantigen receptor has a targeting effect on specific tumor cells and heterogeneous tumor cells, the constructed immune cell expressing the chimeric antigen receptor mobilizes the function of endogenousNKG2D while targeting tumor cells expressing specific antigens, the heterogeneous tumor cells are targeted, and the clearing and killing effects on the specific tumor cells and the heterogeneous tumor cells are realized.

Description

technical field [0001] The invention belongs to the technical field of cellular immunotherapy, and relates to a gene-modified immune cell and its preparation method and application. Background technique [0002] Chimeric antigen receptor T cells, also known as CAR-T cells, use genetic engineering technology to combine single-chain variable regions (scFv) that specifically recognize antigens with T cell co-stimulatory and activation signals (such as CD28, 4-1BB, OX40, CD3ζ, etc.) are connected in series and expressed on T cells, thereby endowing T cells with the function of specifically recognizing the target protein and producing a killing effect on cells expressing the target protein. The prepared CAR-T cells are reinfused into the tumor patient, and the purpose of eliminating tumor cells can be achieved by exerting the effect of CAR-T cells targeting specific tumor antigens. At present, the use of CD19-targeting CAR-T cells in the treatment of leukemia has achieved good r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/62C12N15/867C12N7/01C12N5/10A61K39/00A61P35/00C12R1/93
CPCC07K16/303C07K16/30C07K14/7051C07K14/4705C12N15/86C12N7/00C12N5/0636A61K39/001168A61K39/0011A61P35/00C07K2319/03C07K2317/622C07K2319/33C07K2319/32C12N2740/15021C12N2740/15043C12N2510/00C12N2800/107A61K2039/5158
Inventor 李鹏李尚霖汤朝阳赵若聪姚瑶胡朵
Owner SHENZHEN IN VIVO BIOMEDICINE TECH LTD